logo

Tyson Jumps 7.46% on Earnings Beat, Virtuix Plunges 17%, Microbot Sinks 34% as Stocks React to Q3 Results

Authored By HDFC SKY | Published at: Nov 17, 2026 08:47 AM IST

Tyson Jumps 7.46% on Earnings Beat, Virtuix Plunges 17%, Microbot Sinks 34% as Stocks React to Q3 Results

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Mumbai, 17 November 2026: U.S. stocks saw mixed movements as investors reacted to quarterly earnings, corporate acquisitions, strategic investments and fresh equity offerings. Tyson Foods rallied on an earnings beat, while several small-cap stocks plunged despite operational progress. Meanwhile, major deals and dilution concerns shaped trading across multiple sectors.

Tyson Foods Shares Surge 7.46% as Q4 Earnings Beat Estimates and Beef Outlook Improves

Tyson Foods Inc. (NYSE: TSN) reported fourth-quarter adjusted earnings of $0.61 per share, exceeding analysts’ estimates of $0.60. Revenue was reported at $14.59 billion, above the consensus forecast of $14.1 billion. The company also indicated that its Beef business could return to profitability in fiscal 2027, following substantial losses in fiscal 2026.

Despite beating quarterly earnings expectations, Tyson’s adjusted operating income declined approximately 41% to $361 million from $608 million in the corresponding quarter last year. The Beef segment recorded an adjusted operating loss of $171 million, while Chicken operating income fell to $389 million from $562 million. Prepared Foods generated $321 million in quarterly operating income, with an operating margin of 12.6%.

For fiscal 2027, Tyson expects sales to decline between 3.5% and 5.5%, partly reflecting lower beef production volumes and limited cattle availability. The company forecasts adjusted operating income of $1.7 billion to $2.15 billion. Its Beef segment could record an adjusted operating loss of $300 million or deliver a profit of up to $100 million, supported by plant closures and lower operating costs.

Meanwhile, Tyson reported fiscal 2026 sales of $56.42 billion, up 3.6% year on year, while adjusted earnings per share declined 17% to $3.44. Free cash flow increased to $1.66 billion from $1.18 billion, and total debt declined by $1.08 billion.

Following the earnings announcement, Tyson Foods shares were trading at $63.21, up 7.46% ($4.39) from the previous close of $58.82, as of 10:45:49 AM EST on November 16, 2026. The stock opened at $60.90 and recorded a high of $65.34 and a low of $60.46 during the session.

Dawson Geophysical Shares Fall 3.60% as Q3 Revenue Declines 50% and Losses Widen

Dawson Geophysical Company (NASDAQ: DWSN) reported third-quarter 2026 revenue of $11.4 million, down 50% from $22.7 million in the corresponding quarter of 2025. The company recorded a net loss of $5.2 million, or $0.17 per share, compared with a net loss of $2.5 million in the year-ago quarter. Negative Adjusted EBITDA stood at $2 million, against positive Adjusted EBITDA of $0.2 million in the third quarter of 2025.

Recognised fee revenue declined 27% to $10.8 million, while gross margin contracted to 2% from 15%. The quarterly net loss included $0.8 million in strategic transaction costs. Two large channel crew projects scheduled for the third quarter were postponed to the fourth quarter because of government permitting issues, leaving the company operating two small channel crews during the period.

For the first nine months of 2026, Dawson reported fee revenue of $57.4 million, up 47% year on year. Its net loss narrowed to $0.9 million, or $0.03 per share, from $2.5 million, or $0.08 per share, in the corresponding period of 2025. Adjusted EBITDA increased to $9.5 million from $1.4 million.

The company plans to deploy three large channel crews and three additional small channel crews in the United States in November. It also resumed Canadian operations in October and expects to begin its first geothermal data acquisition project in November. Management highlighted increasing demand for seismic services across oil and gas, geothermal and carbon capture markets.

As of September 30, 2026, Dawson held $2.8 million in cash, had a working capital deficit of $6.2 million and had fully drawn its $3.6 million credit facility. By October 31, cash had increased to $6 million, while outstanding credit facility borrowings stood at $3.5 million.

Dawson Geophysical shares were trading at $1.63, down 3.60% ($0.06) from the previous close of $1.69, as of 11:10:43 AM EST on November 16, 2026. The stock opened at $1.66 and recorded a high of $1.68 and a low of $1.6006 during the session.

Also Read: What Is the New York Stock Exchange (NYSE)?

Galectin Therapeutics Reports 56% Lower Q3 Loss as Belapectin Advances Towards Phase 3 Trial

Galectin Therapeutics Inc. (NASDAQ: GALT) reported a net loss applicable to common stockholders of $3.6 million, or $0.04 per share, for the third quarter ended September 30, 2026, compared with a loss of $8.2 million, or $0.13 per share, in the corresponding period of 2025. The reduction was primarily driven by a change in the fair value of derivative liabilities and lower interest expenses.

Research and development expenses declined to $1.6 million from $2.6 million a year earlier, mainly due to the timing of expenditures associated with the NAVIGATE clinical trial. General and administrative expenses increased to $1.8 million from $1.6 million, reflecting higher non-cash stock-based compensation expenses.

The company also provided an update on its lead drug candidate, belapectin, which targets galectin-3 and is being developed for metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis with portal hypertension. Galectin submitted its registrational Phase 3 trial protocol to the US Food and Drug Administration (FDA) during the third quarter after reaching agreement on key trial design elements, including the primary endpoint and dosage.

At the American Association for the Study of Liver Diseases (AASLD) Annual Meeting, the company presented new analyses from its NAVIGATE Phase 2b/3 trial. The findings showed a 15.9% placebo-adjusted improvement in predicted clinically significant portal hypertension risk at 18 months, with a p-value of 0.04.

Separately, Chairman Richard E. Uihlein converted approximately $105.8 million in outstanding principal and accrued interest from five credit facilities into 34.38 million common shares, effective July 31, 2026. As of September 30, the company held $11.7 million in cash and cash equivalents, along with $10 million available under its chairman-provided credit line. Management expects existing resources to fund planned operations and research activities through June 2027.

Galectin Therapeutics shares were trading at $3.1029, up 1.73% ($0.0529) from the previous close of $3.05, as of 11:26:53 AM EST on November 16, 2026. The stock opened at $3.11 and recorded a high of $3.21 and a low of $2.99 during the session.

RenX Enterprises Shares Decline 2.34% Despite Record Q3 Revenue Growth of 27.6%

RenX Enterprises Corp. (NASDAQ: RENX) reported record third-quarter 2026 revenue of $4.49 million, up 27.6% from $3.52 million in the corresponding quarter of 2025. Revenue also increased 5.4% sequentially from $4.26 million in the second quarter, marking the company’s third consecutive quarter of sequential growth. Gross profit rose 13.2% sequentially to $1.54 million, while gross margin expanded to 34.3%, its highest level in 2026.

Despite revenue growth, the company reported a net loss of $8.7 million, or $3.27 per share, compared with $8.0 million in the previous quarter. The third-quarter loss included $5.7 million in interest expenses, of which approximately $4.1 million represented non-cash amortisation of debt discounts and issuance costs. EBITDA improved to a loss of $2.3 million from $7.2 million in the first quarter.

The Logistics segment generated record revenue of $3.40 million, with operating income increasing 61% sequentially to $416,000, marking its third consecutive profitable quarter. The Compost Sales segment recorded revenue of $1.09 million and narrowed its operating loss by 16% to $766,000.

RenX also completed construction and installation of its Microtec mill in Myakka City, Florida, in October 2026. The company targets initial substrate production in January 2027, following commissioning and electrical energisation. Management aims to achieve operating cash flow breakeven in the Compost Sales segment during the first half of 2027. However, the company stated that achieving its objectives will require additional capital.

RenX Enterprises shares were trading at $1.25, down 2.34% ($0.03) from the previous close of $1.28, as of 11:32:59 AM EST on November 16, 2026. The stock opened at $1.24 and recorded a high of $1.35 and a low of $1.14 during the session.

Venu Holding Assets Rise 59% to $587.6 Million as Revenue Grows 5%

Venu Holding Corporation (NYSE American: VENU) reported total assets of $587.6 million as of September 30, 2026, an increase of $217.1 million, or 59%, from $370.5 million at the end of 2025. Property and equipment rose 70% to $519.8 million. The live entertainment venue developer also reported net tangible assets of $4.83 per common share.

Total revenue for the first nine months of fiscal 2026 increased 5% year over year to $14.1 million from $13.4 million. Restaurant revenue climbed 34% to just over $3 million in the third quarter, while nine-month restaurant revenue increased 26% to approximately $8.7 million.

VENU reported more than $300 million in cumulative Luxe FireSuite and Aikman Club sales across operating and development venues. At Ford Amphitheater, average revenue per show increased to $609,000 from $552,000, while net ticket prices rose to $143 from $126.

The company completed construction of Regent Bank Amphitheater, targeting its opening on New Year’s Eve 2026, while Sunset Amphitheater McKinney is progressing towards completion in the first quarter of 2027. VENU also closed a $60 million sale-leaseback involving land beneath the McKinney venue and its parking garage.

Shares of Venu Holding Corporation were trading at $1.13, unchanged (0.00%) from the previous close of $1.13, as of 11:34:56 AM EST on November 16, 2026. The stock opened at $1.10 and recorded a high of $1.155 and a low of $1.12 during the session.

Also Read: How to invest in US stocks

Nixxy Shares Fall 5.81% as Q3 Revenue Declines 7.81% Despite Narrower Losses

Nixxy, Inc. (NIXX) reported lower revenue but a narrower net loss for the third quarter ended September 30, 2026. Sales declined 7.81% year over year to $29.33 million from $31.81 million in the corresponding quarter of 2025. Net loss narrowed to $2.12 million from $2.20 million.

Basic and diluted loss per share from continuing operations were both $0.07, compared with $0.09 a year earlier, representing an improvement of 22.22%. Basic and diluted loss per share on an overall basis also stood at $0.07, against $0.10 in the prior-year quarter.

For the nine months ended September 30, 2026, Nixxy reported sales of $74.51 million, up from $46.44 million in the corresponding period last year. Net loss narrowed substantially to $3.88 million from $11 million. Basic and diluted loss per share from continuing operations improved to $0.14 from $0.49, while overall basic and diluted loss per share declined to $0.14 from $0.59.

Nixxy shares were trading at $0.1735 as of 11:55:08 a.m. EST on November 16, down $0.0107, or 5.81%, from the previous close of $0.1842. The stock opened at $0.1815 and traded between $0.1734 and $0.1815 during the session. Volume stood at 54,630 shares, compared with an average volume of 502,428.

The quarterly results showed a reduction in losses alongside weaker sales, while nine-month revenue increased and the net loss narrowed compared with the previous year.

Virtuix Shares Plunge 17.14% Despite Revenue Beat as Quarterly Net Loss Widens

Virtuix Holdings Inc. (NASDAQ: VTIX) reported second-quarter fiscal 2027 revenue of $1.19 million, up 21% from $984,812 a year earlier and 55% sequentially. Revenue exceeded the market estimate of $975,000 by 22.06%. Loss per share was $0.19, compared with the estimated loss of $0.20, representing a 5% positive surprise.

Omni One revenue more than doubled, increasing 105% year over year to $1.1 million following its June 2026 launch for Meta Quest. The number of Omni One unit orders increased 3.3 times year over year. Enterprise orders rose 45%, supported by repeat orders from Tesla for its Optimus humanoid robot programme and a first order from Figure AI.

Despite revenue growth, quarterly net loss widened to $6.37 million from $1.87 million a year earlier. Loss per share increased to $0.19 from $0.09. Operating expenses rose to $5.13 million from $1.94 million, reflecting higher stock-based compensation, marketing investment and public-company costs. Adjusted EBITDA loss was $3.64 million, compared with $1.17 million. Gross margin declined to 25% from 41%, partly due to a shift in sales mix towards Omni One.

For the six months, revenue was $1.96 million versus $2.02 million, while net loss increased to $13.54 million from $4.17 million. Cash stood at $4.96 million on September 30.

Virtuix shares traded at $0.4901 as of 12:09:18 p.m. EST, down 17.14% from the previous close of $0.5915. The stock opened at $0.5917 and ranged between $0.4900 and $0.5932 during the session.

The company also signed a non-binding letter of intent to acquire STS International for approximately $12 million, subject to due diligence, financing and other closing conditions.

22nd Century Shares Plunge 31.70% Despite 66% Revenue Growth and Narrower Operating Loss

22nd Century Group, Inc. (NASDAQ: XXII) reported third-quarter 2026 revenue of $4.8 million, a 66% increase from $2.9 million in the second quarter, supported by higher cigarette sales and expanding distribution of its Pinnacle-branded products. Gross profit improved to $0.4 million from a gross loss of $0.3 million in the preceding quarter.

Operating expenses remained broadly unchanged at approximately $3 million, while the operating loss narrowed to $2.6 million from $3.3 million. Net loss from continuing operations also declined to $2.6 million from $3.3 million. Adjusted EBITDA loss improved to $2.2 million from $2.9 million. The figures exclude discontinued operations related to the company’s exit from the hemp and cannabis business.

Cigarette revenue increased to $3.9 million from $2.3 million, reflecting higher carton volumes, improved pricing and a shift towards higher-margin cigarette products. Filtered cigar revenue remained at $0.7 million, while distribution revenue from other tobacco products was $0.1 million. VLN reduced-nicotine cigarette revenue remained approximately $30,000.

The company recorded a 166% quarterly increase in retail point-of-sale pack sales of Pinnacle VLN and Pinnacle Pure products. It expanded shipments to around 150 additional stores across metropolitan New York and northern New Jersey, secured approvals in 13 more states and signed a distribution agreement with Gopuff.

After quarter-end, 22nd Century raised approximately $5.8 million through an at-the-market equity offering and used $1.2 million to redeem preferred stock.

Shares traded at $0.5260 as of 12:08:52 p.m. EST, down 31.70% from the previous close of $0.7701. The stock opened at $0.5545 and ranged between $0.4621 and $0.5924 during the session.

Microbot Medical Shares Plunge 34.08% Despite LIBERTY Utilization Growth and Customer Expansion

Microbot Medical Inc. reported third-quarter 2026 revenue of $72,000, down from $241,000 in the second quarter. The company attributed the sequential decline to seasonal variations and the timing of customer re-orders.

Despite lower revenue, utilisation of its LIBERTY Endovascular Robotic System increased 44% compared with Q2. Microbot expanded its customer base to 12 accounts from 10, adding health systems in North Carolina and California. The company also signed an exclusive distribution agreement for the LIBERTY System in Israel, extending its international commercial presence.

Gross margin was negatively affected by higher costs, including inventory write-downs and expenses associated with prior production. Microbot said manufacturing efficiencies are improving. It ended the quarter with approximately $62 million in cash and equivalents to support its commercial strategy and ongoing operations.

Shares of Microbot Medical (MBOT) fell 34.08% to $0.6452 as of 12:14:19 p.m. EST on November 16, declining $0.3335 from the previous close of $0.9787. The stock opened at $0.6500 and traded between $0.5222 and $0.6600 during the session. Trading volume reached 8,771,880 shares, compared with an average volume of 732,451.

Also Read: US Stock Market Timings

Diamondback Energy Shares Fall 2.41% as Reported $5 Billion Double Eagle Deal Nears

Diamondback Energy is reportedly nearing a roughly $5 billion acquisition of a drilling portfolio from Texas-based producer Double Eagle, according to the Financial Times. The proposed transaction would involve the purchase of Double Eagle V, which is backed by private equity firm EnCap Investments, and expand Diamondback’s presence in the Permian Basin.

The Financial Times cited people familiar with the matter. Reuters said it could not immediately verify the report. Diamondback, Double Eagle and EnCap did not immediately respond to requests for comment outside regular business hours. The transaction could be announced as soon as early next week and is expected to involve a combination of cash and stock, the report said.

The potential acquisition follows Diamondback’s recent agreement with private equity firm KKR to acquire Five Point Infrastructure’s 70% stake in Deep Blue Midland Basin, a Permian Basin water infrastructure company. Diamondback has been expanding its regional operations, including through its $26 billion acquisition of Endeavour Energy Partners in 2024. In February 2025, it also acquired certain Double Eagle units for $4.08 billion in cash and stock.

Diamondback Energy (FANG) shares traded at $180.48, down $4.45, or 2.41%, as of 12:15:22 p.m. EST on November 16. The stock opened at $181.78, compared with the previous close of $184.93, and ranged between $177.12 and $181.85 during the session. Trading volume was 1.22 million shares, against an average of 2.44 million.

Nine Energy Service Shares Rise 1.08% as American Cementing Acquisition Boosts Revenue Outlook

Nine Energy Service, Inc. (NYSE American: NINE) has entered into a definitive agreement to acquire American Cementing, LLC, from an affiliate of Argonaut Private Equity, expanding its cementing operations across the Rockies, Bakken and Northeast regions. The acquisition is expected to increase Nine’s pro forma revenue by more than 35%, with American Cementing contributing approximately $200 million in annual revenue. For the year ended December 31, 2025, American Cementing reported revenue of $206.6 million, net income of $18.4 million and Adjusted EBITDA of $17 million.

Nine expects to generate annual synergies of $2 million to $5 million in 2027. The transaction is also expected to increase availability under its asset-based revolving credit facility by approximately $25 million, strengthening liquidity. The consideration includes approximately 3.93 million Nine shares and $7 million in cash, with the newly issued shares representing around 22% of the company’s outstanding common stock after closing. The acquisition is expected to be completed in the first quarter of 2027, subject to shareholder approval and customary conditions.

Nine Energy Service shares were trading at $7.50, up $0.08 or 1.08%, as of 9:46:06 AM EST on November 16, 2026. The stock opened at $7.50, compared with its previous close of $7.42, and recorded a high of $7.56 and a low of $7.45 during the session.

Ameris Bancorp Shares Fall 0.35% as $1.2 Billion Bank Acquisition Expands Florida Presence

Ameris Bancorp (NYSE: ABCB) has entered into a definitive agreement to acquire Bank of Central Florida Holding Company in an all-stock transaction, strengthening its presence across Central Florida. Bank of Central Florida operates seven financial centres in the greater Lakeland and Tampa markets, with approximately $1.2 billion in assets, $851 million in loans and $1.1 billion in deposits as of September 30, 2026.

Under the agreement, shareholders of Bank of Central Florida Holding Company will receive 0.6279 Ameris shares for each share held, representing an implied value of $51.80 per share based on Ameris’s November 12 closing price. The transaction is expected to close in the first quarter of 2027, subject to regulatory and shareholder approvals.

Ameris Bancorp shares were trading at $82.56, down $0.29 or 0.35%, as of 12:18:52 PM EST on November 16, 2026. The stock opened at $83.04, compared with its previous close of $82.85, and recorded a high of $84.40 and a low of $82.39 during the session.

Blackstone Digital Infrastructure Shares Surge 5.93% on $5 Billion AWS Data Centre Acquisition

Blackstone Digital Infrastructure Trust (NYSE: BXDC) has agreed to acquire a 75% controlling interest in two joint ventures with Amazon Web Services (AWS), valuing the data centre portfolio at approximately $5 billion. The portfolio comprises 13 newly constructed facilities with a combined capacity of 647 megawatts, including nine buildings in northern Indiana and four in Mississippi.

AWS will retain a 25% stake and lease the entire portfolio under triple-net agreements with an initial 12-year term, potentially extendable to 32 years. The transaction carries an initial capitalisation rate of 7% and is expected to close in the fourth quarter of 2026. Separately, the company reported third-quarter funds from operations of $15.6 million, or $0.15 per share, exceeding analysts’ estimate of $0.13 per share.

Blackstone Digital Infrastructure Trust shares were trading at $17.68, up $0.99 or 5.93%, as of 12:22:43 PM EST on November 16, 2026. The stock opened at $17.24, compared with its previous close of $16.69, and recorded a high of $18.25 and a low of $17.02 during the session.

Our Next Energy to Go Public Through $1 Billion SPAC Merger With Wen Acquisition

Our Next Energy (ONE), a U.S.-based lithium iron phosphate (LFP) battery manufacturer, has entered into a definitive business combination agreement with Wen Acquisition Corp (Nasdaq: WENN), paving the way for ONE to become a publicly traded company under the proposed ticker symbol ONEE.

The transaction values the combined company at approximately $1 billion, comprising $600 million in pre-money equity value and up to $400 million in gross proceeds, including $300 million held in trust and a $100 million private investment in public equity (PIPE).

ONE operates two manufacturing facilities in Michigan, serving defence, rail and grid customers. The company has generated $40 million in cumulative revenue and secured more than $200 million in binding multi-year contracts. The transaction is expected to close in the first half of 2027, subject to shareholder approvals and customary conditions.

Cyabra Soars 104%, Global Mofy AI Surges 192% as T1 Energy, Medline and Zenta Face Dilution Risks

T1 Energy shares plunged 17.5% after announcing a $100 million at-the-market equity offering to fund its solar manufacturing facility and working capital, raising dilution concerns. The selloff was compounded by an SEC investigation into its 45X tax credit disclosures, weak Q3 results, and a shareholder law firm probe. Shares touched a 52-week low of $1.50 amid broader market weakness.

Cyabra shares surged after announcing a strategic investment agreement worth up to $40 million over three years, including an initial $10 million cash investment and $5.6 million in debt conversion. The deal also includes cancelling $2.8 million in outstanding debt and potential additional funding of $30 million. Proceeds will support business expansion, technology development, working capital, and efforts to maintain its Nasdaq listing.

Medline shares faced potential selling pressure after major shareholders, including Blackstone, Carlyle and GIC, launched a public offering of 60 million shares, with an option for another 9 million. Medline will receive no proceeds. Separately, the company agreed to repurchase $200 million in shares and partnership interests, subject to completion of the offering.

Zenta Group shares faced potential dilution after announcing an at-the-market offering of up to $6.47 million in Class A ordinary shares through EF Hutton. The Macau-based company can sell shares at prevailing market prices at its discretion, with no obligation to complete the offering. Proceeds, if raised, will support working capital and general corporate purposes as it expands its AI and data solutions business.

Also Read: What Are Fractional Shares? 

Aramark, Onto Boost Buybacks; Invitation Homes Faces $2B Activist Demand as SelectQuote Executes 1-for-20 Split

Aramark (ARMK) authorised a new $1 billion share repurchase program and increased its quarterly dividend by 17% to $0.14 per share. The dividend is payable on December 16 to shareholders of record as of December 4, signalling confidence in its free cash flow generation.

Onto Innovation (ONTO) approved a new share repurchase program of up to $400 million, replacing its previous authorisation and reflecting confidence in its business performance and industry outlook. Pixelworks (PXLW) increased its share repurchase authorisation by $5 million, bringing the total program size to $10 million.

Empery Digital (EMPD) repurchased 194,625 shares during the week ended November 13 under its $200 million buyback program, at an average price of $2.09 per share. Invitation Homes (INVH) faced shareholder pressure after Land & Buildings issued an open letter urging the company to deliver at least $2 billion in annual capital returns through home sales, share repurchases or special dividends.

Tiptree (TIPT) set November 16 as the record date for its $0.06 per-share dividend, payable on November 23. SelectQuote (SLQT) completed its 1-for-20 reverse stock split, effective at 11:59 p.m. ET on November 16. Split-adjusted trading is expected to begin November 17 as the company seeks to regain NYSE listing compliance.

Today’s trading reflected mixed investor sentiment, with earnings surprises and improving business outlooks supporting gains in stocks such as Tyson Foods, while widening losses and revenue weakness weighed on smaller companies. Major acquisitions, strategic investments, equity offerings and shareholder returns also shaped market activity, keeping investors focused on profitability, growth prospects and potential dilution risks.

Disclaimer

The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.

Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI
Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy